{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:14:42Z","timestamp":1767849282716,"version":"3.49.0"},"reference-count":75,"publisher":"Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada","issue":"ACS-2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.14745\/ccdr.v39i00a02","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T20:18:00Z","timestamp":1519849080000},"page":"1-20","source":"Crossref","is-referenced-by-count":2,"title":["STATEMENT FOR TRAVELLERS AND YELLOW FEVER"],"prefix":"10.14745","volume":"39","author":[{"given":"This statement was prepared by P.","family":"Charlebois","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5795","published-online":{"date-parts":[[2013,3]]},"reference":[{"issue":"40","key":"key20180228151757_r1","first-page":"349","article-title":"Yellow fever vaccine. WHO position paper","volume":"78","author":"World Health Organization","year":"2003","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"key20180228151757_r2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1473-3099(01)00016-0","article-title":"Yellow fever: an update","volume":"1","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"key20180228151757_r3"},{"key":"key20180228151757_r4","unstructured":"World Health Organization. Fact Sheet: Yellow Fever. Geneva: WHO [website]. Available from: www.who.int\/mediacentre\/factsheets\/fs100\/en; 2011."},{"issue":"8","key":"key20180228151757_r5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/jama.300.8.960","article-title":"Yellow fever: 100 years of discovery","volume":"300","year":"2008","journal-title":"JAMA"},{"issue":"34","key":"key20180228151757_r6","first-page":"370","article-title":"Yellow fever in the WHO African and American Regions, 2010","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"key20180228151757_r7"},{"issue":"6","key":"key20180228151757_r8","first-page":"50","article-title":"Progress in the control of yellow fever in Africa","volume":"80","author":"World Health Organization","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"issue":"4","key":"key20180228151757_r9","first-page":"25","article-title":"Yellow fever in Africa and Central and South America, 2008\u20132009","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"key20180228151757_r10","unstructured":"World Health Organization. Global Alert and Response: Yellow Fever. Geneva: WHO [website]. Available from: www.who.int\/csr\/disease\/yellowfev\/en; 2011."},{"issue":"6","key":"key20180228151757_r11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1086\/511869","article-title":"Yellow fever: epidemiology and prevention","volume":"44","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"key20180228151757_r12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/516111","article-title":"Imported yellow fever in a United States citizen","volume":"25","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"19","key":"key20180228151757_r13","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1001\/jama.287.19.2499-JWR0515-3-1","article-title":"Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002","volume":"287","year":"2002","journal-title":"JAMA"},{"issue":"14","key":"key20180228151757_r14","first-page":"303","article-title":"Fatal yellow fever in a traveler returning from Venezuela, 1999","volume":"49","author":"Centers for Disease Control and Prevention (CDC)","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"key20180228151757_r15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jcv.2004.12.001","article-title":"Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium","volume":"33","year":"2005","journal-title":"J Clin Virol"},{"key":"key20180228151757_r16","unstructured":"Public Health Agency of Canada. National Notifiable Diseases On-Line. Ottawa: PHAC [website]. Available from: http:\/\/dsol-smed.hc-sc.gc.ca\/dsol-smed\/ndis\/list-eng.php; 2005."},{"issue":"5","key":"key20180228151757_r17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/rmv.584","article-title":"The enigma of yellow fever in East Africa","volume":"18","year":"2008","journal-title":"Rev Med Virol"},{"issue":"5","key":"key20180228151757_r18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1708-8305.2008.00225.x","article-title":"Yellow fever recommendations for tourists to Kenya: a flawed risk assessment?","volume":"15","year":"2008","journal-title":"J Travel Med"},{"key":"key20180228151757_r19"},{"issue":"8","key":"key20180228151757_r20","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1473-3099(11)70147-5","article-title":"The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever","volume":"11","author":"Informal WHO Working Group on Geographic Risk for Yellow Fever","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"37","key":"key20180228151757_r21","first-page":"401","article-title":"Revised recommendations for yellow fever vaccination for international travellers, 2011","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"issue":"2","key":"key20180228151757_r22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-0934(03)00129-0","article-title":"Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay","volume":"110","year":"2003","journal-title":"J Virol Methods"},{"issue":"2","key":"key20180228151757_r23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0166-0934(03)00128-9","article-title":"MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination","volume":"110","year":"2003","journal-title":"J Virol Methods"},{"key":"key20180228151757_r24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v38i00a03","article-title":"Statement on Personal Protective Measures to Prevent Arthropod Bites - Update","volume":"38","author":"Committee to Advise on Tropical Medicine and Travel","year":"2012","journal-title":"Can Commun Dis Rep"},{"issue":"14","key":"key20180228151757_r25","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S1286-4579(02)00028-X","article-title":"The epidemiology of yellow fever in Africa","volume":"4","year":"2002","journal-title":"Microbes Infect"},{"issue":"4","key":"key20180228151757_r26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4269\/ajtmh.1998.59.650","article-title":"First recorded outbreak of yellow fever in Kenya, 1992-1993. II. Entomologic investigations","volume":"59","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"key20180228151757_r27"},{"key":"key20180228151757_r28"},{"issue":"6","key":"key20180228151757_r29","first-page":"895","article-title":"Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine","volume":"59","year":"1981","journal-title":"Bull World Health Organ"},{"key":"key20180228151757_r30"},{"issue":"2","key":"key20180228151757_r31","first-page":"9","article-title":"Review of adverse events reported following use of yellow fever vaccine--Canada, 1987-2000","volume":"28","year":"2002","journal-title":"Can Commun Dis Rep"},{"issue":"29","key":"key20180228151757_r32","first-page":"217","article-title":"Adverse events following yellow fever vaccination","volume":"76","author":"World Health Organization","year":"2001","journal-title":"Wkly Epidemiol Rec"},{"issue":"44","key":"key20180228151757_r33","article-title":"Adverse events associated with 17D-derived yellow fever vaccination - United States, 2001\u20132002","volume":"51","year":"2002","journal-title":"MMWR CDC Surveill Summ"},{"issue":"2","key":"key20180228151757_r34","first-page":"244","article-title":"Age-related risk of adverse events following yellow fever vaccination in Australia","volume":"28","year":"2004","journal-title":"Commun Dis Intell Q Rep"},{"issue":"3","key":"key20180228151757_r35","first-page":"307","article-title":"Surveillance of adverse events following immunisation: Australia, 2000-2002","volume":"27","year":"2003","journal-title":"Commun Dis Intell Q Rep"},{"issue":"15","key":"key20180228151757_r36","first-page":"2758","article-title":"17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005","volume":"25","year":"2007","journal-title":"Vaccine"},{"key":"key20180228151757_r37","unstructured":"Public Health Agency of Canada. Canadian Immunization Guide. Evergreen Edition; Part 4: Active Vaccines, Yellow Fever Vaccine. Ottawa: PHAC [website]. Available from: www.phac-aspc.gc.ca\/publicat\/cig-gci\/p04-yfev-fiej-eng.php; 2012"},{"issue":"48","key":"key20180228151757_r38","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"key20180228151757_r39","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0091-6749(99)70245-9","article-title":"Anaphylaxis from yellow fever vaccine","volume":"103","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"key20180228151757_r40","first-page":"191","article-title":"Administration of egg-containing vaccines to egg-allergic children","volume":"50","year":"1993","journal-title":"Arch Fr Pediatr"},{"issue":"25","key":"key20180228151757_r41","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Yellow Fever Vaccine Safety Working Group","year":"2005","journal-title":"Vaccine"},{"issue":"10","key":"key20180228151757_r42","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.trstmh.2007.06.013","article-title":"Acute viscerotropic disease following vaccination against yellow fever","volume":"101","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"key20180228151757_r43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1708-8305.2008.00209.x","article-title":"Yellow fever-associated viscerotropic disease in Barcelona, Spain","volume":"15","year":"2008","journal-title":"J Travel Med"},{"issue":"17-18","key":"key20180228151757_r44","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.vaccine.2004.01.026","article-title":"Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX","volume":"22","year":"2004","journal-title":"Vaccine"},{"issue":"9276","key":"key20180228151757_r45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","year":"2001","journal-title":"Lancet"},{"issue":"50","key":"key20180228151757_r46","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","year":"2007","journal-title":"Vaccine"},{"issue":"30","key":"key20180228151757_r47","first-page":"643","article-title":"Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996-2001","volume":"50","author":"Centers for Disease Control and Prevention (CDC)","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"32","key":"key20180228151757_r48","first-page":"287","article-title":"Meeting of Global Advisory Committee on Vaccine Safety, 18-19 June 2008","volume":"83","author":"World Health Organization","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"issue":"3","key":"key20180228151757_r49","first-page":"200","article-title":"Safety and efficacy of yellow fever vaccine in children less thanone-year-old","volume":"9","year":"1990","journal-title":"West Afr J Med"},{"issue":"2","key":"key20180228151757_r50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0031-3955(05)70216-9","article-title":"Immunization for children traveling abroad","volume":"47","year":"2000","journal-title":"Pediatr Clin North Am"},{"key":"key20180228151757_r51","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"key20180228151757_r52","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1086\/322968","article-title":"Travel vaccines and elderly persons: review of vaccines available in the United States","volume":"33","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"5","key":"key20180228151757_r53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/hv.1.5.2221","article-title":"Yellow fever 17D vaccine safety and immunogenicity in the elderly","volume":"1","year":"2005","journal-title":"Hum Vaccin"},{"issue":"6","key":"key20180228151757_r54","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3201\/eid0706.010605","article-title":"Advanced age a risk factor for illness temporally associated with yellow fever vaccination","volume":"7","author":"GeoSentinel Yellow Fever Working Group","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"key20180228151757_r55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-3156.1998.00164.x","article-title":"Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study","volume":"3","year":"1998","journal-title":"Trop Med Int Health"},{"issue":"3","key":"key20180228151757_r56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0264-410X(98)00051-6","article-title":"Exposure to yellow fever vaccine in early pregnancy","volume":"17","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"key20180228151757_r57","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/infdis\/168.6.1520","article-title":"Congenital yellow fever virus infection after immunization in pregnancy","volume":"168","year":"1993","journal-title":"J Infect Dis"},{"issue":"3","key":"key20180228151757_r58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0035-9203(93)90156-K","article-title":"Yellow fever vaccination and pregnancy: a four-year prospective study","volume":"87","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9","key":"key20180228151757_r59","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.vaccine.2005.09.033","article-title":"The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil","volume":"24","author":"Campinas Group on Yellow Fever Immunization during Pregnancy","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"key20180228151757_r60","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-3156.2007.01851.x","article-title":"Early exposure to yellow fever vaccine during pregnancy","volume":"12","author":"Campinas Group of Yellow Fever Immunization during Pregnancy","year":"2007","journal-title":"Trop Med Int Health"},{"issue":"2","key":"key20180228151757_r61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1708-8305.2007.00175.x","article-title":"Impact of vaccines given during pregnancy on the offspring of women consulting a travel clinic: a longitudinal study","volume":"15","year":"2008","journal-title":"J Travel Med"},{"issue":"5","key":"key20180228151757_r62","first-page":"130","article-title":"Transmission of yellow fever vaccine virus through breast-feeding - Brazil, 2009","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"key20180228151757_r63","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1503\/cmaj.100619","article-title":"Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk","volume":"183","year":"2011","journal-title":"CMAJ"},{"key":"key20180228151757_r64","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","year":"2002","journal-title":"MMWR Recomm Rep"},{"issue":"10","key":"key20180228151757_r65","first-page":"524","article-title":"[Yellow fever vaccination in non-immunocompetent patients]","volume":"38","year":"2008","journal-title":"Med Mal Infect"},{"issue":"1","key":"key20180228151757_r66","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ncpneph1003","article-title":"Immunizations for renal transplant candidates and recipients","volume":"5","year":"2009","journal-title":"Nat Clin Pract Nephrol"},{"issue":"4","key":"key20180228151757_r67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.trre.2008.07.001","article-title":"Vaccination of the solid organ transplant recipient","volume":"22","year":"2008","journal-title":"Transplant Rev (Orlando)"},{"issue":"3","key":"key20180228151757_r68","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1086\/314031","article-title":"Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases","volume":"31","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"4","key":"key20180228151757_r69","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0609.2004.00218.x","article-title":"Yellow fever vaccine: a successful vaccination of an immunocompromised patient","volume":"72","year":"2004","journal-title":"Eur J Haematol"},{"issue":"5","key":"key20180228151757_r70","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00002030-200403260-00020","article-title":"Yellow fever vaccine is safe and effective in HIV-infected patients","volume":"18","year":"2004","journal-title":"AIDS"},{"issue":"6","key":"key20180228151757_r71","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2174\/157016210793499277","article-title":"Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients","volume":"8","year":"2010","journal-title":"Curr HIV Res"},{"issue":"5","key":"key20180228151757_r72","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/597006","article-title":"Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients","volume":"48","author":"Swiss HIV Cohort Study","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key20180228151757_r73","article-title":"The immunocompromised traveller","volume":"33","author":"Committee to Advise on Tropical Medicine and Travel","year":"2007","journal-title":"Can Comm Dis Rep"},{"issue":"9438","key":"key20180228151757_r74","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(04)17017-7","article-title":"History of thymoma and yellow fever vaccination","volume":"364","author":"Yellow Fever Vaccine Safety Working Group","year":"2004","journal-title":"Lancet"},{"issue":"17","key":"key20180228151757_r75","first-page":"145","article-title":"Evidence-based medicine","volume":"20","author":"Committee to Advise on Tropical Medicine and Travel","year":"1994","journal-title":"Can Commun Dis Rep"}],"container-title":["Canada Communicable Disease Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/13vol39\/acs-dcc-2\/assets\/pdf\/acs-dcc-2-eng.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T02:03:02Z","timestamp":1570845782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/13vol39\/acs-dcc-2\/assets\/pdf\/acs-dcc-2-eng.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":75,"journal-issue":{"issue":"ACS-2","published-online":{"date-parts":[[2013,3]]},"published-print":{"date-parts":[[2013,3]]}},"URL":"https:\/\/doi.org\/10.14745\/ccdr.v39i00a02","relation":{},"ISSN":["1481-8531"],"issn-type":[{"value":"1481-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}